AFT Pharmaceuticals hits $200m revenue milestone despite profit dip
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
David Chaplin: Why govt wrote off funds' climate reports
What to make of the change in standard.
Restaurant Brands NZ's indy directors say low-ball offer tasty enough
Below-valuation offer for Restaurant Brands NZ recommended by independent directors.
More big companies bet they can still grow without hiring
The firms looking to keep headcount flat.
NZ risks losing edge as Australia takes lead in cleaner jet fuel
Experts warn SAF delay could cost jobs and growth.
